Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands

OBJECTIVES: Intratypic molecular variants of human papillomavirus (HPV) type-16 and -18 exist. In the Netherlands, a bivalent vaccine, composed of recombinant L1 proteins from HPV-16 and -18, is used to prevent cervical cancer since 2009. Long-term vaccination could lead to changes in HPV-16 and -18...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Audrey J., Sonsma, Jan A., Vriend, Henrike J., van der Sande, Marianne A. B., Feltkamp, Mariet C., Boot, Hein J., Koopmans, Marion P. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829201/
https://www.ncbi.nlm.nih.gov/pubmed/27070907
http://dx.doi.org/10.1371/journal.pone.0152782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829201/
https://www.ncbi.nlm.nih.gov/pubmed/27070907
http://dx.doi.org/10.1371/journal.pone.0152782

Ejemplares similares